Access the full text.
Sign up today, get DeepDyve free for 14 days.
Kenneth Lee, R. Scully (2000)
Mucinous Tumors of the Ovary: A Clinicopathologic Study of 196 Borderline Tumors (of Intestinal Type) and Carcinomas, Including an Evaluation of 11 Cases With `Pseudomyxoma Peritonei'The American Journal of Surgical Pathology, 24
E. Oliva, M. Amin, R. Jimenez, R. Young (2002)
Clear Cell Carcinoma of the Urinary Bladder: A Report and Comparison of Four Tumors of Mullerian Origin and Nine of Probable Urothelial Origin With Discussion of Histogenesis and Diagnostic ProblemsThe American Journal of Surgical Pathology, 26
H. Hoerl, W. Hart (1998)
Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term follow-up.The American journal of surgical pathology, 22 12
S. Logani, E. Oliva, P. Arnell, M. Amin, R. Young (2005)
Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinomaModern Pathology, 18
S. Ashizawa, F. Brunicardi, Xiao-ping Wang (2004)
PDX-1 and the PancreasPancreas, 28
M. Riopel, B. Ronnett, R. Kurman (1999)
Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas.The American journal of surgical pathology, 23 6
J. Quirk, N. Natarajan (2005)
Ovarian cancer incidence in the United States, 1992-1999.Gynecologic oncology, 97 2
M. Offield, T. Jetton, P. Labosky, M. Ray, R. Stein, M. Magnuson, B. Hogan, C. Wright (1996)
PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum.Development, 122 3
W. Hart (2005)
Mucinous tumors of the ovary: a review.International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 24 1
(2005)
Diagnostic value of transcriptional factors and differential cytokeratins in separating primary pulmonary from metastatic mucinous cystadenocarcinoma
Lee (2003)
Pathology and Genetics: Tumors of the Breast and Female Genital Organs
R. Werling, H. Yaziji, C. Bacchi, A. Gown (2003)
CDX2, a Highly Sensitive and Specific Marker of Adenocarcinomas of Intestinal Origin: An Immunohistochemical Survey of 476 Primary and Metastatic CarcinomasThe American Journal of Surgical Pathology, 27
J. Rutgers, R. Scully (1988)
Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysisCancer, 61
M. Kim (2005)
The Usefulness of CDX-2 for Differentiating Primary and Metastatic Ovarian Carcinoma: An Immunohistochemical Study Using a Tissue MicroarrayJournal of Korean Medical Science, 20
D. Castrillon, Kenneth Lee, M. Nucci (2002)
Distinction Between Endometrial and Endocervical Adenocarcinoma: An Immunohistochemical StudyInternational Journal of Gynecological Pathology, 21
(2003)
Surface epithelial-stromal tumors
Koulchl Nomura, S. Aizawa (1996)
Clinicopathologic and mucin histochemical analyses of 90 cases of ovarian mucinous borderline tumors of intestinal and müllerian typesPathology International, 46
T. Moriya, Y. Mikami, K. Sakamoto, M. Endoh, J. Takeyama, Takashi Suzuki, S. Mochizuki, Mika Watanabe, Y. Monobe, H. Sasano (2003)
Endocervical-like mucinous borderline tumors of the ovary: clinicopathological features and electron microscopic findingsMedical Electron Microscopy, 36
S. Park, H. Kim, E. Hong, W. Kim (2002)
Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.Human pathology, 33 11
R. Vang, A. Gown, T. Barry, D. Wheeler, B. Ronnett (2006)
Ovarian Atypical Proliferative (Borderline) Mucinous Tumors: Gastrointestinal and Seromucinous (Endocervical-Like) Types are Immunophenotypically DistinctiveInternational Journal of Gynecological Pathology, 25
V. Kaimaktchiev, L. Terracciano, L. Tornillo, H. Spichtin, Dimitra Stoios, M. Bundi, V. Korcheva, M. Mirlacher, M. Loda, G. Sauter, C. Corless (2004)
The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomasModern Pathology, 17
H. Cathro, M. Stoler (2002)
Expression of cytokeratins 7 and 20 in ovarian neoplasia.American journal of clinical pathology, 117 6
T. Loy, J. Quesenberry, S. Sharp (1992)
Distribution of CA 125 in adenocarcinomas. An immunohistochemical study of 481 cases.American journal of clinical pathology, 98 2
D. Melloul (2004)
Transcription Factors in Islet Development and Physiology: Role of PDX‐1 in Beta‐Cell FunctionAnnals of the New York Academy of Sciences, 1014
H. Hui, R. Perfetti (2002)
Pancreas duodenum homeobox-1 regulates pancreas development during embryogenesis and islet cell function in adulthood.European journal of endocrinology, 146 2
W. Hart, H. Norris (1973)
Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behaviorCancer, 31
C. O'Neill, M. Deavers, A. Malpica, H. Foster, W. McCluggage (2005)
An Immunohistochemical Comparison Between Low-Grade and High-Grade Ovarian Serous Carcinomas: Significantly Higher Expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in High-Grade NeoplasmsThe American Journal of Surgical Pathology, 29
J. Rutgers, R. Scully (1988)
Ovarian mixed‐epithelial papillary cystadenomas of borderline malignancy of mullerian type: A clinicopathologic analysisCancer, 61
B. Ritz-Laser, B. Gauthier, A. Estreicher, A. Mamin, Thierry Brun, F. Ris, P. Salmon, P. Halban, D. Trono, J. Philippe (2003)
Ectopic expression of the beta-cell specific transcription factor Pdx1 inhibits glucagon gene transcriptionDiabetologia, 46
I. Rodríguez, J. Irving, J. Prat (2004)
Endocervical-like Mucinous Borderline Tumors of the Ovary: A Clinicopathologic Analysis of 31 CasesThe American Journal of Surgical Pathology, 28
I. Rodríguez, J. Prat (2002)
Mucinous Tumors of the Ovary: A Clinicopathologic Analysis of 75 Borderline Tumors (of Intestinal Type) and CarcinomasThe American Journal of Surgical Pathology, 26
RESEARCH ARTICLE Intestinal Type and Endocervical-like Ovarian Mucinous Neoplasms are Immunophenotypically Distinct Entities Xiaoqi Lin, MD, PhD,* Jennifer L. Lindner, DO,w Jan F. Silverman, MD,w and Yulin Liu, MDw rimary ovarian mucinous carcinoma constitutes ap- Abstract: Ovarian mucinous neoplasm (OMN) is traditionally Pproximately 10% of all primary ovarian malignant 1,2 classified as either intestinal type or endocervical-like subtypes. neoplasms. Traditionally ovarian mucinous neoplasm The 2 subtypes represent different clinicopathologic character- (OMN) is classified as benign, borderline, and carcinoma istics. The immunophenotype of the 2 subtypes has not been on the basis of the morphologic features of the lining adequately investigated. In this study, we investigated 14 epithelial cells and stromal invasion. Two subtypes, intestinal type OMNs (borderline and adenocarcinoma) and endocervical-like and intestinal type, have been described. 12 endocervical-like OMNs (borderline and adenocarcinoma) The 2 subtypes have different clinicopathologic charac- for their expression of PDX-1, CDX-2, CA-125, CK7, CK20, teristics. WT-1, D2-40, and TTF-1. We also included 15 colorectal The borderline intestinal type OMN accounts for adenocarcinomas metastatic in the ovary, as they may 85% to 90% of borderline OMNs with patients having a 2,4 occasionally mimic OMN. The intestinal type OMNs were mean age of 35 to 47
Applied Immunohistochemistry & Molecular Morphology – Wolters Kluwer Health
Published: Oct 1, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.